Dar, Altaf A <br/><br/>
The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.  [electronic resource] 

 -  Journal of the National Cancer Institute  Feb 2015 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djv034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Nuclear--metabolism<br/>Antineoplastic Agents--pharmacology<br/>Biomarkers, Tumor--metabolism<br/>Disease Progression<br/>Female<br/>Gene Dosage<br/>Gene Expression Regulation, Neoplastic<br/>Imidazoles--pharmacology<br/>Immunoblotting<br/>Immunohistochemistry<br/>In Situ Hybridization, Fluorescence<br/>Indoles--pharmacology<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Nude<br/>Molecular Targeted Therapy--methods<br/>Mutation--drug effects<br/>Nerve Tissue Proteins--metabolism<br/>Oximes--pharmacology<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Skin Neoplasms--drug therapy<br/>Sulfonamides--pharmacology<br/>Transcription Factors--metabolism<br/>Vemurafenib<br/>Xenograft Model Antitumor Assays